Fortress Biotech Trademark Details
Word Mark | Fortress Biotech |
---|---|
Status | Alive 731 — Second Extension - Granted |
Previous Owners
Coronado Biosciences, Inc. of Burlington, MA
View all trademarks for Coronado Biosciences, Inc.Serial Number | 86590594 |
---|---|
Status Date | Friday, September 16, 2016 |
Filing Date | Friday, September 16, 2016 |
Attorney | Devon E. White |
Correspondent
DEVON E. WHITE
Wyrick Robbins Yates & Ponton Llp
4101 Lake Boone Trl Ste 300
Raleigh, NC 27607-7525
Wyrick Robbins Yates & Ponton Llp
4101 Lake Boone Trl Ste 300
Raleigh, NC 27607-7525
Case File Statements
Disclaimer with Predetermined Text | "Biotech" |
---|---|
Goods & Services | Medical, biological and pharmaceutical preparations for scientific, research, medical or pharmaceutical use, namely, preparations for the treatment of cancer, autoimmune diseases and disorder, rare diseases, genetic diseases, infectious diseases, central nervous system infections, gastrointestinal infections, genitourinary infections, ocular infections, dermatological infections, immune system infections, liver infections, hepatic infections, neurological disorders, tuberculosis, lung diseases, asthma, hypertension, cardiovascular diseases, immunologic diseases, immunologic deficiency syndromes, tumors, proliferative diseases, inflammatory diseases, inflammatory bowel diseases, inflammatory connective tissue diseases, psoriasis, ophthalmologic diseases, fibrotic diseases, metabolic diseases, dental and oral diseases, neurological diseases, Alzheimer´s disease, Huntington´s disease, Parkinson, cerebral palsy, brain injury, spinal cord injury, seizure disorders, congenital disorders, metabolic disorders, viral and infectious diseases and immune system related diseases and disorders; Pharmaceutical preparations for the prevention and treatment of genetic and congenital disorders, metabolic disorders, infectious diseases, cancer and pain relief; Pharmaceutical products for the treatment and normalization of disorders of the body's circulatory system; Pharmaceutical products for the treatment of diseases of the blood or of the lymphatic circulatory system; Pharmaceutical preparations for the purpose of increasing the effectiveness of other pharmaceutical products; Drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals |
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Thursday, April 16, 2015 |
Primary Code | 005 |
Trademark Timeline
-
Apr 08 2015Trademark application filed with USPTO
-
Apr 11 2015New Application Entered In Tram
-
Apr 16 2015New Application Office Supplied Data Entered In Tram
-
May 13 2015Automatic Update of Assignment of Ownership
-
Jul 16 2015Examiner's Amendment Entered
-
Jul 16 2015Assigned To Lie
-
Jul 16 2015Notification of Examiners Amendment E-Mailed
-
Jul 16 2015Examiners Amendment E-Mailed
-
Jul 16 2015Examiners Amendment -Written
-
Jul 16 2015Assigned To Examiner
-
Jul 17 2015Approved For Pub - Principal Register
-
Jul 25 2015Law Office Publication Review Completed
-
Aug 12 2015Notification of Notice of Publication E-Mailed
-
Sep 01 2015Official Gazette Publication Confirmation E-Mailed
-
Sep 01 2015Published For Opposition
-
Oct 27 2015Noa E-Mailed - Sou Required From Applicant
-
Mar 02 2016Extension 1 Granted
-
Mar 02 2016Extension 1 Filed
-
Mar 02 2016Teas Extension Received
-
Mar 04 2016Notice of Approval of Extension Request E-Mailed
-
Aug 26 2016Extension 2 Filed
-
Aug 26 2016Teas Extension Received
-
Sep 15 2016Case Assigned To Intent To Use Paralegal
-
Sep 16 2016Extension 2 Granted
-
Sep 17 2016Notice of Approval of Extension Request E-Mailed